Skip to main content
. 2023 Feb 28;15(3):797. doi: 10.3390/pharmaceutics15030797

Figure 6.

Figure 6

Temporal and spatial concentration profiles of free-phase fibrinogen for (a) alteplase, (b) tenecteplase, (c) reteplase, and (d) urokinase in the clot. Free-phase FBG concentration in the clot (lower concentration represents higher ICH risk): urokinase < alteplase < tenecteplase < reteplase.